Kathrine Morin

Associate

401.276.6456

More ways to contact Kathrine Morin

Overview
Representative Matters
Insights

Katie assists private equity firms, their portfolio clients, and emerging high-growth companies with a variety of transactional needs. Her experience includes mergers and acquisitions, leveraged buyouts, debt and equity offerings, minority investments, corporate reorganizations, and general corporate counseling. Katie also serves as general outside counsel to both public and private companies, providing comprehensive legal support.

Katie also has experience in public finance, particularly in the issuance of tax-exempt and taxable bonds. She represents issuers and borrowers in general obligation and revenue bond transactions and serves as bond counsel to various cities, towns, and quasi-public agencies.

  • Assisted in representing Imugene Ltd. in a strategic transaction with Precision Biosciences in which Imugene received a worldwide exclusive license to Precision Bioscience’s allogenic CD19 CAR T-cell therapy program for oncology and a related manufacturing facility for total deal consideration valued up to $227 million.
  • Assisted in representing Ambac Financial Group Inc., a financial services holding company, in the purchase of a majority stake in Riverton Insurance Agency, Corp., a New Jersey-based insurance services business.
  • Assisted in representing Legacy Farms LLC, a leading fresh vegetable and fruit grower, shipper, and wholesaler to grocers and food service providers in the Western U.S., in the acquisition of Frieda’s, a California-based specialty produce distributor.
  • Assisted in advising Ambac Financial Group Inc., a financial services holding company, in the purchase of a majority stake in both All Trans Risk Solutions and Capacity Marine Corporation.
  • Assisted in representing Biohaven Pharmaceutical Company Ltd. (NYSE: BHVN) in the sale of its migraine business to Pfizer in a total deal consideration valued at approximately $13 billion.
  • Assisted in representing Greenbacker Capital Management in its investment in Sunrock Distributed Generation.
  • Assisted in representing Oscor, Inc., in its sale of $220 million to Integer Holdings Corporation.
  • Assisted in representing American Tower Corporation in the acquisition of data centers located in Orlando and Atlanta operated by DataSite.
  • Assisted in representing Silver Oak Services Partners, LLC, in the recapitalization of Drive Automotive Services, LLC.
  • Assisted in representing Enhanced Energy Group, Inc., operating as CarbonPoint Solutions, in its sale to Caterpillar Inc.
  • Assisted in representing Shanghai Haohai Biological Technology Co., Ltd., in connection with its $40 million Series A preferred equity investment in Eirion Therapeutics, Inc., and related licensing agreements.
  • Assisted in representing Silver Oak Services Partners, LLC, in its sale of BBG, Inc., to Incline Equity Partners.
  • Assisted in representing KPS Mid-Cap Investments, an affiliate of KPS Capital Partners, in the acquisition of Libertas Copper LLC.
  • Assisted in representing Biohaven Pharmaceutical Holding Company in its acquisition of the remaining 58% interest of Kleo Pharmaceuticals, Inc., which it did not previously own, and the execution of an exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from the Spiegel Lab.
  • Assisted in representing the Seller of Falk Marques Group to Pageant Media US Limited.
  • Assisted in representing Biohaven Pharmaceutical Holding Company and its affiliate BioShin Limited in a $60 million Series A preferred equity financing of BioShin Limited, BioShin’s subsidiary.
Overview

Katie assists private equity firms, their portfolio clients, and emerging high-growth companies with a variety of transactional needs. Her experience includes mergers and acquisitions, leveraged buyouts, debt and equity offerings, minority investments, corporate reorganizations, and general corporate counseling. Katie also serves as general outside counsel to both public and private companies, providing comprehensive legal support.

Katie also has experience in public finance, particularly in the issuance of tax-exempt and taxable bonds. She represents issuers and borrowers in general obligation and revenue bond transactions and serves as bond counsel to various cities, towns, and quasi-public agencies.

Representation Matters
  • Assisted in representing Imugene Ltd. in a strategic transaction with Precision Biosciences in which Imugene received a worldwide exclusive license to Precision Bioscience’s allogenic CD19 CAR T-cell therapy program for oncology and a related manufacturing facility for total deal consideration valued up to $227 million.
  • Assisted in representing Ambac Financial Group Inc., a financial services holding company, in the purchase of a majority stake in Riverton Insurance Agency, Corp., a New Jersey-based insurance services business.
  • Assisted in representing Legacy Farms LLC, a leading fresh vegetable and fruit grower, shipper, and wholesaler to grocers and food service providers in the Western U.S., in the acquisition of Frieda’s, a California-based specialty produce distributor.
  • Assisted in advising Ambac Financial Group Inc., a financial services holding company, in the purchase of a majority stake in both All Trans Risk Solutions and Capacity Marine Corporation.
  • Assisted in representing Biohaven Pharmaceutical Company Ltd. (NYSE: BHVN) in the sale of its migraine business to Pfizer in a total deal consideration valued at approximately $13 billion.
  • Assisted in representing Greenbacker Capital Management in its investment in Sunrock Distributed Generation.
  • Assisted in representing Oscor, Inc., in its sale of $220 million to Integer Holdings Corporation.
  • Assisted in representing American Tower Corporation in the acquisition of data centers located in Orlando and Atlanta operated by DataSite.
  • Assisted in representing Silver Oak Services Partners, LLC, in the recapitalization of Drive Automotive Services, LLC.
  • Assisted in representing Enhanced Energy Group, Inc., operating as CarbonPoint Solutions, in its sale to Caterpillar Inc.
  • Assisted in representing Shanghai Haohai Biological Technology Co., Ltd., in connection with its $40 million Series A preferred equity investment in Eirion Therapeutics, Inc., and related licensing agreements.
  • Assisted in representing Silver Oak Services Partners, LLC, in its sale of BBG, Inc., to Incline Equity Partners.
  • Assisted in representing KPS Mid-Cap Investments, an affiliate of KPS Capital Partners, in the acquisition of Libertas Copper LLC.
  • Assisted in representing Biohaven Pharmaceutical Holding Company in its acquisition of the remaining 58% interest of Kleo Pharmaceuticals, Inc., which it did not previously own, and the execution of an exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from the Spiegel Lab.
  • Assisted in representing the Seller of Falk Marques Group to Pageant Media US Limited.
  • Assisted in representing Biohaven Pharmaceutical Holding Company and its affiliate BioShin Limited in a $60 million Series A preferred equity financing of BioShin Limited, BioShin’s subsidiary.
Insights

Firm News

Troutman Pepper Locke Providence Lawyers Selected as 2025 Rhode Island Monthly Professional Excellence in Law Honorees

Firm News

Eight Locke Lord Providence Lawyers Selected as 2024 Rhode Island Monthly Professional Excellence in Law Honorees

Sponsored Events

Women in Public Finance 26th Annual Conference: Cultivating Connections

Articles + Publications

Locke Lord QuickStudy: Relief for State and Local Governments Impacted by COVID-19‎

See all insights from Kathrine Morin

Top areas of focus

  • Board of directors, Providence Children’s Museum

Education

  • Roger Williams University School of Law, J.D., summa cum laude, 2019, executive articles editor, Roger Williams University Law Review; member, moot court team
  • Cornell University, School of Industrial and Labor Relations, B.S., 2015, industrial and labor relations; varsity swimming

Bar Admissions

  • Rhode Island
  • Co-author, “Relief for State and Local Governments Impacted by COVID-19,” Locke Lord QuickStudy, May 17, 2021.
  • Co-author, “Relief for State and Local Governments Impacted by COVID-19,” Locke Lord QuickStudy, March 17, 2021.
  • Co-author, “Main Street Lending Program – Federal Reserve Announces Expanded Access for Some Businesses While Affiliation Rules Restrict Access for Others,” Locke Lord QuickStudy, June 9, 2020.
  • Co-author, “Help for Main Street: Lender Certifications and Covenants for the Main Street Lending Program,” Locke Lord QuickStudy, June 8, 2020.
  • Co-author, “Help for Main Street: Borrower Certifications and Covenants for the Main Street Lending Program,” Locke Lord QuickStudy, June 8, 2020.
  • Co-author, “Help for Main Street: Federal Reserve Bank of Boston Provides Updated Information on Main Street Lending Program,” Locke Lord QuickStudy, May 29, 2020.
  • Co-author, “Main Street Lending Program Updates Respond to Market Input but Leave Unsolved Problems,” Locke Lord QuickStudy, May 6, 2020.
  • Co-author, “Help for Main Street: Federal Reserve Provides Additional Guidance on Main Street Lending Program,” Locke Lord QuickStudy, May 1, 2020.
  • Co-author, “Help for Main Street: Treasury Department and Federal Reserve Announce Main Street Lending Facilities for Small and Mid-Sized Businesses (including Nonprofits),” Locke Lord QuickStudy, April 10, 2020.